DNMT3A and myelodysplastic syndrome: DNMT3A mutations and deletions have been analyzed in AML (5), chronic myeloid leukemia (CML), chronic myelomonocytic leukemia (CMML), myelodysplastic syndrome (MDS), lymphoma and myeloproliferative neoplasms (MPNs) (6–11).